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Cell deathWe previously showed that, in the rat hepatoma cell line HTC, TNF brings about a non-caspase-dependent,
apoptosis-like process requiring NADPH oxidase activity, an iron-mediated pro-oxidant status, and a
functional acidic vacuolar compartment. This process may thus involve mechanisms such as autophagy or
relocation of lysosomal enzymes, perhaps secondary to the formation of ceramide by acidic sphingomye-
linase. Here we investigated whether ceramide formation contributes to the apoptogenic process. HTC cells
were found to be sensitive to exogenous ceramide and signiﬁcantly protected against TNF by desipramine, an
inhibitor of lysosomal acid sphingomyelinase. However, Bcl-2 transfection and Bcl-xL upregulation by
dexamethasone signiﬁcantly diminished the apoptogenic effect of ceramide but not that of TNF, suggesting
that ceramide is not directly involved in TNF toxicity. Moreover, Bcl-xL silencing precluded dexamethasone-
induced protection against ceramide and, by itself, induced massive death, demonstrating the strict
dependence of HTC cells on Bcl-xL for survival also under standard culture conditions.© 2009 Elsevier B.V. All rights reserved.1. Introduction
Primary hepatocellular carcinoma (HCC) is a malignancy with bad
prognosis because of lack of effective treatments [1]. Although its
etiology has been much looked for, and several risk factors identiﬁed,
the molecular mechanisms that drive the neoplastic transformation of
hepatocytes are still poorly understood.
Malignant transformation is a multiphase process by which cells
accumulate mutations in relevant oncogenes and oncosuppressor
genes that confer a selective growth advantage and, consequently,
promote uncontrolled expansion of privileged clones. Whereas
excessive proliferation relies on the upregulation of positive signals
or the down-regulation of negative ones, insufﬁcient cell deletion
(e.g., programmed cell death) that would counteract proliferation
may reﬂect defects in the extrinsic (receptor-mediated) or intrinsic
(mitochondria-triggered) apoptotic pathways. Hepatocytes have
been categorized as type II cells [2], i.e. cells that require a tight
cooperation and integration of both these apoptotic pathways toorange; BafA1, baﬁlomycin A1;
ethasone; Dpm, desipramine;
dium iodide; aSMNase, acidic
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death receptors. Consequently, aberration in either one of these
pathways can affect the capability of HCC cells to undergo apoptosis
following appropriate stimuli, resulting in resistance to programmed
cell death. Since most chemotherapeutic agents rely on the induction
of apoptosis for their action, such resistance may account for the
unfavorable prognosis of HCC patients.
Among the many apoptogenic stimuli in mammalian cells, TNF has
long been regarded as one of the most effective and, thus, it has been
studied intensively. This particular cytokine can trigger different
signaling cascades, which often converge by activating the caspase
cascade and thereby apoptosis, although other forms of cell death
have also been reported [3]. However, a number of both normal and
neoplastic cells display strong resistance to TNF as well as other
cytotoxic agents. Usually, this is due to various mechanisms of
apoptosis suppression.
HTC cells, an established line of rat hepatoma cells, are resistant to
several apoptogenic agents, TNF included, and may dominantly confer
death resistance to somatic hybrids generated by fusion with
otherwise sensitive cells [4].
We have previously reported that HTC cells can be sensitized to
TNF by the simultaneous exposure to low concentrations of
cycloheximide. This combined treatment causes a non-necrotic,
apoptotic-like form of cell death that, interestingly, requires a properly
functioning lysosomal compartment as well as normal NADPH oxidase
activity [5]. Apart from occasional reports, which implicate stimula-
tion of autophagy [6], the role of lysosomes in TNF cytotoxicity is
Fig. 1. Effect of desipramine and fumonisin on cell death. HTC cells were exposed for
6 h to 20 ng/ml TNF and 10 μg/ml CHX, in the presence of 50 μM desipramine or
fumonisin B1 and subsequently analyzed by ﬂow cytometry. Early apoptosis-like cell
alteration was quantiﬁed as the proportion of cells exposing phosphatidylserine and
excluding propidium iodide. For each sample, at least 5000 cells were analyzed.
Results represent the means±SD of three independent experiments. Statistical
signiﬁcance of the differences was evaluated by one-way ANOVA test, followed by
the Student–Newman–Keuls post test. ⁎⁎⁎: pb0.001 vs TNF/CHX. n.s.: not signiﬁcantly
different vs TNF/CHX.
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secondary to loss of lysosomal membrane integrity. One way this may
occur is generation of the apoptogenic substance ceramide in the
acidic endo-lysosomal compartment [7]. Ceramide, in turn, may also
be cleaved by an acidic lysosomal ceramidase under formation of the
lysosomotropic detergent sphingosine, which labilizes lysosomes if
present in high enough concentrations [8].
This possibility, which is the object of the present investigations, is
supported by our preliminary observation that desipramine (Dpm),
an inhibitor of the acidic sphingomyelinase (aSMNase), protects HTC
cells from the cytotoxic effect of TNF. To clarify the role of ceramide,
we here compared the mechanisms behind the cytotoxic actions of
TNF and ceramide on HTC cells.
2. Materials and methods
2.1. Cell cultures and treatments
HTC cells were grown in a 1:1 mixture of DMEM/Ham's F12 with
10% FBS, 2 mM glutamine, 100 U/ml penicillin, and 100 μg/ml
streptomycin. For experiments, cells were plated at 104/cm2 and, 24 h
later, exposed to 20 ng/ml human recombinant TNF (R&D Systems,
Minneapolis, MN, USA) and 10 μg/ml cycloheximide (CHX) or to
different concentrations of C2-ceramide (Sigma-Aldrich, Milan, Italy).
Culture media and all other reagents and chemicals were from
Sigma-Aldrich (Milan, Italy), except for z-VAD.fmk that was from
Alexis-Biochemicals (San Diego, CA, USA).
2.2. Plasmids and transfections
The control or encoding human Bcl-2 pBABE vectors [9] were
transfected in HTC cells for 16 h with the DOTAP reagent (Roche
Applied Science, Monza, Italy). The cells were then returned to
standard culture conditions and grown for another 24 h before
selection with 10 μg/ml puromycin. While untransfected cells died in
4–8 days, the mock and Bcl-2-transfected growwell in the presence of
puromycin, which was removed 24 h before further experiments. The
expression of hBcl-2 was detected by western blotting, with an anti-
Bcl-2 antibody (Santa Cruz Biotechnology, Heidelberg, Germany).
2.3. Detection and quantiﬁcation of early apoptosis-like alterations
The apoptotic populationwas estimated by counting the fraction of
cells that were positive for phosphatidylserine (PS) and negative for
propidium iodide (PI). The assay was done as previously described [5]
using the Annexin V/PI reagent (Bender MedSystem, Wien, Austria)
coupled to ﬂow cytometric analysis on a FACScan machine (Becton-
Dickinson, Milan, Italy) as described before [5]. For each sample, at
least 5000 cells were acquired and analyzed with the CellQuest
software (Becton-Dickinson).
2.4. Analysis of mitochondrial membrane potential
Changes in the mitochondrial membrane potential were analyzed
using the JC-1 (Invitrogen, San Giuliano Milanese, Italy) technique.
The cells, washed and resuspended in PBS, were stained at room
temperature with 5 μM JC-1 for 10 min in the dark. Red and green
ﬂuorescence were then measured with a FACScan ﬂow cytometer and
analyzed with the CellQuest software. For each sample, at least 5000
cells were analyzed.
2.5. Analysis of lysosomal acidity and morphology
The effects of desipramine (Dpm) and NH4Cl on the acidic
compartment were examined by the acridine orange (AO) technique
[10]. The cells were incubatedwith 5 μg/ml AO in completemedium at37°C for 15 min, rinsed with PBS, detached and analyzed by ﬂow
cytometry. For each sample, at least 10000 cells were analyzed.
For microscopy, cells were grown on chamber slides and treated
with 50 μMDpm or 20mMNH4Cl for 6 h. Then, 5 μg/ml AOwas added
to the medium for 5 min at room temperature. Following two washes
with PBS, cells were observed under Nomarski and ﬂuorescence
optics. Representative ﬁelds were recorded and subsequently pro-
cessed with Photoshop, version 7.0.
In order to further analyze the effect of Dpm,macro-autophagywas
prevented by adding 10 mM 3-MA to the cultures 1 h before Dpm
(50 μM). Moreover, to prevent the supposedly lysosomotropic drug
Dpm to concentrate in the lysosomal compartment, cellswere exposed
to the proton pump inhibitor BafA1 (1 μM) before Dpm addition.
2.6. Bcl-xL expression
For Bcl-xL detection, cells were sonicated in lysis buffer (20 mM
TRIS–Cl, 2 mM EDTA, 150 mM NaCl, 0.5% Triton X-100). 20 μg of
the lysates were resolved on a 12% PAGE. After blotting, the
membranes were incubated overnight at 4°C with a rabbit
polyclonal anti-Bcl-xL (1:500, sc-1041, Santa Cruz Biotechnology)
or for 1 h at room temperature with a mouse monoclonal anti-β-
actin (1:2000, clone AC-15, Sigma-Aldrich) antibody. The blots
were then washed with TBS-Tween 0.05% and incubated with the
appropriate anti-IgG antibody (1:10000, Bio-Rad Laboratories,
Milan, Italy). Chemiluminescent detection was performed with
the Western Blotting Luminol Reagent (Santa Cruz Biotechnology).
For equal loading of lanes, the protein content of each sample was
determined with the Bio-Rad Protein Assay Dye Reagent Concentrate
(Bio-Rad Laboratories).
Quantiﬁcation of Bcl-xL expressionwas obtained with the TotalLab
TL100 analytical software (Nonlinear Dynamics, ver. 2006c, Newcastle
upon Tyne, UK) and expressed as normalized intensity of the band of
interest with respect to the amount of β-actin for each sample.
2.7. Downregulation of Bcl-xL by RNA interference
Bcl-xL was silenced using conditions that efﬁciently knock down
Bcl-xL in HTC cells [11]. 100 nM of the Bcl-xL speciﬁc and control
siRNAs (MWG-Biotech AG, Ebersberg, Germany) were transfected
with Metafectene Pro (Biontex, Martinsried-Planegg, Germany) for
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conditions for another 20 h and then treated with C2-cer or TNF/CHX
for 24 or 6 h in the presence or absence of dexamethasone (Dex)
before being harvested. Cell death and Bcl-xL levels were quantiﬁed as
described above.
2.8. Statistical analysis
The shown results represent the means±SD from at least three
independent experiments. Statistical signiﬁcance of the differences
between groups was analyzed by one-way ANOVA and the Student–
Newman–Keuls post test using the Instat software (GraphPad, San
Diego, CA, USA).
3. Results
3.1. Mechanisms of ceramide-induced cell death in HTC cells
We have previously shown that TNF/CHX treatment is cytotoxic
for HTC cells. TNF toxicity was signiﬁcantly diminished by
baﬁlomycin A1 and ammonium chloride, which both raise the
endo-lysosomal pH. Therefore, a properly functioning acidic com-
partment appeared to be an essential requirement for TNF/CHX-
induced cell death. The contribution of this compartment to a deathFig. 2. Characterization of ceramide-induced cell death. (A) HTC cells were exposed for
24 h to 50 and 75 μM C2-cer and analyzed by ﬂow cytometry using the annexin V/
propidium iodide (PI) test as in Fig. 1. The percentage of necrotic cells was in the range
of 5–7% with no appreciable changes due to treatments. (B) The alteration of
mitochondrial membrane potential following C2-cer treatment (as in A) was evaluated
by the JC-1 technique. In both experiments, the pan-caspase inhibitor z-VAD.fmk
(50 μM) was added 1 h before C2-cer. For each experiment, at least 5000 cells were
acquired and analyzed. Data and statistical analysis as in Fig. 1. ⁎ and ⁎⁎⁎: pb0.05 and
pb0.001 vs controls. § and §§§: pb0.05 and pb0.001 vs C2-cer at the indicated
concentrations. n.s.: not signiﬁcantly different vs controls.
Fig. 3. Effect of Bcl-2 on ceramide and TNF toxicity. HTC cells were stably transfected
with a retroviral vector encoding a human Bcl-2 cDNA (dark bars) and treated with
either 50 μM C2-cer for 24 h (A) or TNF/CHX as before for 6 h (B). As a control, the
empty vector was stably transfected (empty bars). After treatment, cells were stained
with annexin V/PI and analyzed by ﬂow cytometry. For each experiment, at least
5000 cells were acquired and analyzed. Data and statistical analysis as in Fig. 1. The
insert in A shows the expression of human Bcl-2 in control (Mock) and Bcl-2
transfected cells (Bcl-2). ⁎⁎⁎: pb0.001 vs controls. §§§ and §: pb0.001 and pb0.05 vs
mock-transfected cells.receptor-mediated cytotoxicity may rely on various molecular
mechanisms [12,13], among which ceramide generation has been
suggested as an important, though not exclusive occasion [14].
To explore whether ceramide contributed to TNF/CHX-dependent
death, HTC cells were treated with this combination of drugs in the
presence of desipramine (Dpm, 50 μM) or fumonisin B1 (Fumo,
50 μM), which respectively inhibit aSMNase and ceramide synthase.
Whereas no effect of Fumowas detected, Dpm signiﬁcantly prevented
cell death (Fig. 1). This ﬁnding may be compatible with the hypothesis
that the formation of ceramide by aSMNase contributes to cellular
death at least to some extent, although in other experiments (not
shown) no protectionwas afforded by Dpm at lower concentrations (5
and 20 μM), usually adequate to protect cells from ceramide generated
in the acidic compartment.
To verify this hypothesis, the sensitivity of HTC cells to
exogenous ceramide was evaluated. The cells were treated with
different concentrations of C2-ceramide (C2-cer) for 24 h when it
was found that C2-cer had produced a well deﬁned phosphatidyl-
serine-positive population (Fig. 2A). As inferred from the protection
afforded by the pan-caspase inhibitor z-VAD.fmk at 50 μM (Fig. 2A
and B) or 20 μM concentration (not shown), caspases were
involved in this C2-cer-induced death (type I programmed cell
death). By contrast, we found caspase inhibitors totally ineffective
Fig. 4. Effect and molecular mechanism of protection by dexamethasone from
ceramide and TNF toxicity. HTC cells were incubated for 18 h with 1 μM Dex, and
subsequently with 50 μM C2-cer (A, C) or TNF/CHX as before (B, D) for 24 and 6 h,
respectively. Bcl-xL (29 kDa) was measured by western blotting (A, B), and cell death
by ﬂow cytometry by exposure to annexin V/PI (C, D). At least 5000 cells were
analyzed for each condition. Changes in the relative abundance of Bcl-xL with respect
to control cells are indicated. Actin: β-actin band (42 kDa); the asterisk in panel B
indicates non-speciﬁc bands due to antibody cross-reactivity. Data and statistical
analysis as in Fig. 1. ⁎⁎⁎: pb0.001 vs controls. §§§ and §: pb0.001 and pb0.05 vs
50 μM C2-cer (panel C) or TNF/CHX (panel D).
Fig. 5. Downregulation of Bcl-xL and its effects on cell death. To eradicate Bcl-xL, HTC
cells were transiently transfected with sequence-speciﬁc siRNAs duplexes. As a control,
a non-speciﬁc duplex with a GC content similar to that of speciﬁc siRNAs was used.
Silenced and control cells were treated for 24 h with 50 μM C2-cer and 1 μM Dex as
indicated, and subsequently harvested for Bcl-xL detection by western blotting (A) or
for FACS analysis after staining with annexin V/PI (B). The data represent the
means±SD of two independent experiments, assayed in triplicate. siNS: non-speciﬁc
silencing duplexes; siBcl-xL: siRNAs speciﬁcally targeting Bcl-xL sequence. Changes in
the relative abundance of Bcl-xL with respect to non-silenced cells are indicated.
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proportion of cells with altered mitochondrial potential (Fig. 2B)
suggests that caspase activation was triggered by the intrinsic
apoptotic pathway.
3.2. Effects of Bcl-2 expression and dexamethasone on C2-cer- and TNF-
induced cell death
Bcl-2 and other anti-apoptotic proteins of this family, including
Bcl-xL, protect against apoptosis triggered by several apoptogenic
agents. In particular, Bcl-2 depresses the effects of ceramide in various
experimental models [15]. Thus, we investigated the effects of
ectopically expressed Bcl-2 (Fig. 3A, insert) on the toxicity elicited
by TNF/CHX and C2-cer, the latter used at the lowest effective
concentration (50 μM). Bcl-2- and mock-transfected HTC cells were
treatedwith TNF/CHXor C2-cer for 6 and 24 h, respectively. Stable Bcl-
2-transfectants were signiﬁcantly protected from C2-cer (Fig. 3A), but
not from TNF/CHX (Fig. 3B). Therefore, ceramide toxicity progressed
through a Bcl-2-sensitive pathway, while TNF/CHX toxicity took place
through a Bcl-2-insensitive one.
To validate this hypothesis, HTC cells were exposed to TNF/CHX
or C2-cer in the presence of dexamethasone (Dex), a synthetic
glucocorticoid that, via Bcl-xL upregulation, protects HTC cells from
apoptosis by serum starvation or UV-C [11]. HTC cells exposed to Dex
for 18 h underwent a clearcut elevation of the Bcl-xL protein,
Fig. 7. Effect of NH4Cl and desipramine on the lysosomal compartment. HTC cells were
treated for 6 h with 20 mM NH4Cl (A) or 50 μM desipramine (D). Control cells (C) did
not receive any treatment. After 15 min loading with 5 μg/ml acridine orange at 37 °C,
cells were detached by trypsin and immediately analyzed by ﬂow cytometry.
Histograms represent red ﬂuorescence collected from at least 10000 cells for each
condition. Note declined AO uptake following exposure to NH4Cl (A) as a result of
lysosomal alkalinization, while the broad, right-deviated peak following exposure to
Dpm (D) suggests a largely expanded lysosomal compartment. Data acquisition and
analysis were performed with CellQuest Analytical Software.
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required to sensitize the cells to TNF, only slightly reduced this
increase (Fig. 4B). However, only the C2-cer-induced cell death was
markedly suppressed by Dex, while the protection against TNF/CHX
was only marginal (Fig. 4C–D), further conﬁrming that TNF- and
C2-cer-induced toxicity rely on different mechanisms. In addition,
this ﬁnding also proves that Bcl-xL upregulation, similarly to ectopic
Bcl-2 expression, can afford protection from selected death stimuli in
HTC cells.
Dpm, like other tricyclic antidepressants, has been reported to
raise the intracellular concentration of glucocorticoids by inhibiting
their extrusion [16], and could thus mimic the effect of Dex on the
Bcl-xL levels. However, in HTC cells the intracellular Bcl-xL levels
were not modiﬁed by Dpm (data not shown). To further demonstrate
that Bcl-xL was responsible for the protection afforded by Dex against
C2-cer, we reduced its level by the RNA interference technique.
Bcl-xL-speciﬁc siRNAs caused the Bcl-xL protein to decrease to almost
undetectable levels in HTC cells, whether exposed or not to Dex
(Fig. 5A). Under these conditions, however, Dex did not further
prevent C2-cer-induced cell death, thus conﬁrming the criticality of
Bcl-xL in suppression of ceramide-induced death (Fig. 5B). Note-
worthily, siRNA-mediated depletion of Bcl-xL by itself elicited cell
death, independently of any additional cytotoxic treatment.
Altogether, the above results support the view that TNF toxicity on
HTC cells is not mediated by ceramide. Consequently, they also imply
that the protection afforded by Dpm against TNF/CHX cannot be
ascribed to interference with ceramide metabolism.Fig. 6. Effect of desipramine and ammonium chloride on cell morphology. HTC cells were treated for 6 h with TNF/CHX alone (B) or in the presence of either 50 μM desipramine (D) or
20 mMNH4Cl (F). As controls, cells were left untreated (A) or exposed to Dpm (C) or NH4Cl (E) alone. Note heavy and moderate vacuolization of cells after exposure to Dpm and NH4Cl,
respectively. Phase-contrast pictures (magniﬁcation 40×) were recorded with a digital camera and details representative of each condition composed with Photoshop, version 7.0.
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While exploring the possible mechanisms by which HTC cells are
protected by Dpm from TNF/CHX-induced death, we noticed that the
drug affected cell morphology and caused the appearance of a
number of variously-sized, optically clear vacuoles (Fig. 6C–D). Such
vacuoles were similar to, albeit more prominent than, those
observed in cells treated with NH4Cl (Fig. 6E–F), an agent that
alkalizes lysosomal pH. We compared cells treated for 6 h with Dpm
or NH4Cl for changes in their lysosomal compartment, using ﬂow
cytometry and light microscopy following staining with the
lysosomotropic ﬂuorochrome acridine orange (AO). As expected,
the red ﬂuorescence was signiﬁcantly reduced by NH4Cl (Fig. 7). By
contrast, Dpm shifted the ﬂuorescence to values deﬁnitely higher
than in controls. By Nomarski and ﬂuorescence microscopy (Fig. 8),
control cells (panels A–C) displayed a number of small red
ﬂuorescent granules corresponding to lysosomes. In NH4Cl-treated
cells (panels D–F), which were slightly rounded up, many of the
ﬂuorescent granules were moderately enlarged, while their total
number appeared somewhat decreased (perhaps because of their
lower detectability due to the pH increase). Dpm-treated cells were
characterized by large and intensely red lysosomes (in goodFig. 8. Structural and morphological alterations of the lysosomal compartment. Cells were e
exposure to 5 μg/ml acridine orange at room temperature, samples were observed by Nomar
cells treated with NH4Cl; G–I cells treated with Dpm. Representative ﬁelds were acquired wi
following exposure to NH4Cl. Cells exposed to Dpm are rounded up, partly degenerated and s
G and I) demonstrate that the large and optically clear vacuoles resulting from desipramineagreement with the FACS data) and, on image overlays, they
perfectly matched the optically clear vacuoles (panel G–I, arrow-
heads). Obviously, Dpm causes an expansion of the lysosomal
compartment and a change from many small lysosomes to a few
large ones. We considered the possibility that these alterations
reﬂect enhanced autophagy or osmotic swelling of the lysosomes.
The depression of macro-autophagy by 3-MA for a short period of
time neither affected the cell morphology nor altered the vacuoliza-
tion caused by Dpm (Fig. 9). By contrast, this vacuolization was
completely suppressed on alkalinization of the lysosomal compart-
ment by BafA1. This result strongly indicates that Dpm is a highly
lysosomotropic drug that accumulates in the endo-lysosomal
compartment raising its osmotic pressure and, thereby, inducing
the formation of large vacuoles under consideration.
4. Discussion
TNF, one of the most powerful inducers of apoptosis and necrosis,
may trigger different mechanisms that lead to caspase activation,
which in turn results in classic apoptotic cell death [2]. This particular
cytokine, however, can also elicit additional kinds of non-necrotic cell
death that substantially differ from conventional apoptosis.xposed to 20 mM NH4Cl or 50 μM desipramine for 6 h. Following a 5 min long ensuing
ski (panels A, D, G) and ﬂuorescence microscopy (panels B, E, H). A–C: control cells; D–F
th a digital camera and overlaid (C, F, I) using Photoshop. Note slightly rounded up cells
how numerous enlarged lysosomes, suggestive of osmotic swelling. Arrowheads (panels
treatment match with the intense red ﬂuorescent acidic vesicles.
Fig. 9. Effect of 3-MA and BafA1 on desipramine-induced vacuolization. HTC cells were treated for 4 h with 50 μMdesipramine in the presence of 10 mM 3-MA (D) or 1 μM BafA1 (F).
As controls, cells were left untreated (A) or exposed to Dpm (B) or 3-MA (C) and BafA1 (E) alone. Both 3-MA and BafA1 were added to the cultures 1 h before the addition of Dpm.
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CHX brings about an atypical apoptosis-like but caspase-independent
death mode [5], in which the acidic vacuolar compartment as well as
NADPH oxidase is involved. NADPH oxidase was found implicated also
in TNF-induced necrotic death of L929 cells [17]. Apart from the well-
known role in the autophagy-associated cell death (reviewed in [18]),
the involvement of lysosomes in death pathways mostly proceeds
through membrane labilization, with consequent release of hydro-
lases to the cytoplasm [19] (reviewed in [20]) or via ceramide
generation due to the action of aSMNase [7,21]. TNF may cause deathby either of these mechanisms [22]. In our previous report [5], using
standard techniques we could, however, detect neither any increase in
total cathepsin activity nor release of lysosomal enzymes to the
cytosol in TNF-treated HTC cells. In addition, selective cathepsin
inhibitors did not suppress TNF toxicity, although drugs that raise
lysosomal pH, such as baﬁlomycin A and ammonia did.
In the present study, we investigated whether any generation of
ceramide by aSMNase is involved in the TNF-triggered death of HTC
cells. The protection from TNF/CHX that was afforded by Dpm, which
is known to suppress ceramide generation in the acidic compartment
1189R. Autelli et al. / Biochimica et Biophysica Acta 1793 (2009) 1182–1190[23], indeed suggested the involvement of this lipid mediator in death
signal transduction. However, while HTC cell death induced by TNF/
CHX previously was found to be both caspase- and mitochondria-
independent, we here show that, in contrast, death by ceramide is
both caspase- and mitochondria-dependent. It follows that cell injury
by these two agents proceeds through unrelated pathways, thereby
implying that Dpm protects from TNF by mechanisms other than
interference with ceramide metabolism and aSMNase activity. Since
we observed that Dpm is a lysosomotropic drug that causes alterations
of the acidic vacuolar compartment of HTC cells due to osmotic
swelling owing to its accumulation in the lysosomal compartment
[24], it seems probable that its protective effect is mediated by an
interference with the lysosomal compartment that prevent its normal
functioning — something that seems to be a requirement for TNF/
CHX.
In agreement with previous reports, HTC cells express no
detectable levels of Bcl-2 [25], which is one of the most protective
factors against agents that activate the intrinsic apoptotic pathway,
ceramide included [15]. As expected, enforced Bcl-2 expression indeed
protected HTC cells from ceramide. By contrast, ectopic Bcl-2
expression afforded no protection against TNF/CHX exposure, but
rather somewhat increased the sensitivity to this cytokine. This
ﬁnding clearly lends further support to the view that TNF and
ceramide trigger diverse death mechanisms in HTC cells.
Consistent evidence was provided by experiments using Dex, a
synthetic glucocorticoid, which is known to both induce [26] and
protect from [27] apoptosis, depending on the cell type. The anti-
apoptotic effect of Dex relies on upregulated expression of protective
factors such as Bcl-2 and Bcl-xL [28,29], and this mechanism has
been shown to be effective in HTC cells as well [11]. In the present
study, Dex did not attenuate TNF toxicity despite an efﬁcient Bcl-xL
induction, but completely abrogated ceramide toxicity. This protec-
tion can be ascribed to Bcl-xL, since protection was no longer
observed following Bcl-xL silencing, when the cells rather under-
went massive death. Since upregulation of Bcl-xL, or enforced
expression of Bcl-2, both prevented ceramide-induced cell death,
our results also suggest that these two Bcl-2 family members can
substitute for each other in shutting down signals that trigger the
intrinsic death pathway and in granting increased death resistance
to hepatoma cells.
In conclusion, the results presented in this study strongly support
the view that, even if dependent on the endo-lysosomal apparatus and
effectively prevented by Dpm, TNF/CHX toxicity to HTC cells does not
involve ceramide as a mediator. Further it is caspase- and mitochon-
dria-independent and is antagonized by neither ectopic Bcl-2
expression, nor exposure to Dex, which upregulates Bcl-xL expression.
In contrast, cell death due to ceramide exposure proceeds via
activation of caspases and of the intrinsic apoptotic pathway and is
strongly antagonized by ectopic Bcl-2, or by the Bcl-xL overexpression
brought about by Dex.
These ﬁndings strongly argue against the notion that the
attenuation of TNF toxicity afforded by 50 μM Dpm is accounted for
by it being an aSMNase inhibitor. Rather the observation that this drug
elicits pronounced morphological changes of the lysosomal compart-
ment indicative of osmotic swelling suggests that the protective effect
is due to interference with normal endo-lysosomal function.
Finally, though beyond the scopes of the present study, but in
consistency with a previous report [11], we observed that Bcl-xL
silencing was sufﬁcient to induce massive HTC cell death under
completely normal culture conditions, indicating that these hepatoma
cells are critically dependent on Bcl-xL for survival. Interestingly, it
was shown that Bcl-2 is undetectable in various human hepatoma cell
lines, which, conversely, express high levels of Bcl-xL [30]. Moreover,
the same authors also reported that human HCCs have signiﬁcantly
higher Bcl-xL and lower Bcl-2 levels than adjacent normal liver tissue,
thus supporting the view that deregulated expression of Bcl-xLcontributes to the development of HCCs and suggesting that Bcl-xL
may be a signiﬁcant therapeutic target.
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